China Q1 2020 Imported Non-special Use Cosmetics Filing Data and Analysis of Filing Application Rejections
May 12, 2020
A total of 3353 imported non-special use products were filed in Q1 2020, an obvious decline compared with the Q3 and Q4 data in 2019.
The pass rate of the technical review decreased to 58% in Q1 2020 from an average rate of 80% last year. There are four major causes for rejection of filing applications.
According to the filing data publicized on China National Medical Products Administration's (NMPA) online filing information query system, a total of 3353 imported non-special use products were filed in Q1 2020, translating to a decline in products filed of around 15% and 12% compared with the Q3 and Q4 2019. Undoubtedly, the COVID-19 pandemic was the major contributor to this decline.
Please Log in
or Sign up
(FREE) to read the full content.
Copyright: unless otherwise stated all contents of this website are ©2020 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact firstname.lastname@example.org